Study of the Effects of Fabrazyme Treatment on Lactation and Infants

Clinical trial NCT00230607 · TERMINATED

Trial details

NCT number: NCT00230607
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Fabry Disease Alpha Galactosidase A Deficiency

Start date: 2006-05-28
Primary completion: 2024-02-09
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.